Less than a month after its acquisition of neonatal specialty lab Sequenom, LabCorp acquired obstetric and gynecology testing firm ClearPath Diagnostics from private equity firm Shore Capital Partners for an undisclosed amount. Here is a quick review of the deal and the larger strategy it serves. The LabCorp Strategy "The Sequenom and ClearPath acquisitions represent…
LabCorp Continues Shopping Spree by Acquiring ClearPath Diagnostics
Less than a month after its acquisition of neonatal specialty lab Sequenom, LabCorp acquired obstetric and gynecology testing firm ClearPath Diagnostics from private equity firm Shore Capital Partners for an undisclosed amount. Here is a quick review of the deal and the larger strategy it serves. The LabCorp Strategy "The Sequenom and ClearPath acquisitions represent […]